9-1

PSY 550 Milestone Two: Research and Clinical Formulation

Student’s name

Institution affiliation

Course

Instructor’s name

Date

Test and Assessment Development Analysis: Test Two

E. Describe the test’s cut scores for normal versus at-risk or clinically significant .

The WAIS-IV test distinguishes normal from at-risk/clinically significant levels with cut scores. The median score is 100, and values between 90-109 are average, above 110 are high, 80-89 indicate at-risk circumstances, and below 80 imply varying clinical importance. According to Cohen et al. (2022), the test scores clinical scales, with higher values indicating stronger characteristics or behaviors. MMPI-2 T-scores distinguish normal from clinically significant values. T-scores above 70 show psychopathy in a certain category, suggesting mental health issues. Understanding these cut scores helps identify at-risk persons like Ms. Z and guide solutions based on her results.

F. Assess any cultural concerns for how they impact the effectiveness of the test administration.

Haddlesey (2016) states that neuropsychological tests like the MMPI-2 are usually developed and normed on white, English-speaking populations, which may bias assessment results for other cultural groups. Cultural factors are significant for MMPI-2 administration. Despite cultural differences, the MMPI-2, which caters to a wider demographic, is suitable for Ms. Z (Floyd & Gupta, 2022; Kagan, 2019). Also, when in administering the WAIS-IV, cultural considerations may affect test administration efficacy. Cultural and language limitations can hinder comprehension and performance. Studies reveal culturally distinct communities score lower (Serin, 2022). Cultural biases can impair test validity and reliability if ignored. English proficiency helps Ms. Z take the test without cultural bias and get accurate results.

G. Determine if any ethical issues affect the test administration.

Cohen et al. (2022) emphasize test result confidentiality because the MMPI-2 assesses personality and psychopathology. The MMPI-2-RF addresses ethical issues such cultural sensitivity and biases in MMPI-2 administration. These improvements aim to eliminate ethnic and cultural differences in psychological trait interpretation, reducing ethical difficulties (Floyd & Gupta, 2022). These factors mirror Ms. Z's scenario, making the MMPI-2 suitable for her test. Extensive norming and validation in the WAIS-IV reduce ethical difficulties like cultural prejudice (Serin, 2022). Since Ms. Z is within the test's normed age range and linguistic ability, these ethical problems are mitigated, making the test ethical for her assessment.

H. Assess the methods of interpreting and communicating the results for their appropriateness.

Interpreting MMPI-2 results for Ms. Z would involve using T-scores to communicate her scores relative to the population's norm (Floyd & Gupta, 2022). This method ensures clarity and accuracy in conveying her psychological profile, aiding in decision-making and treatment planning. Percentile ranks will be vital to interpret Ms. Z’s WAIS-IV data. I will make comparisons of IQ scores using percentile ranks. Interpretations must account for culture and circumstance. Confidence intervals will also help in explaining scores and their implications.

Clinical Formulation

B. Determine a diagnosis based on the data provided.

C. Interpret the psychometric data from the test results to address the reason for the referral.

Interpreting the psychometric data from the tests addresses Ms. Z's intention to return to college after depression. The WAIS-IV findings indicate her cognitive talents are average, supporting her academic potential. But her Working Memory Index (WMI) score suggests a problem that could hinder her capacity to handle challenging tasks. This knowledge can inform recommendations like giving assignments and tests more time, lowering the initial course load, and offering mental health treatments like therapy and medication management for anxiety and depression. Given Ms. Z's MMPI-2 TRT score, which shows treatment resistance, a thorough treatment plan should include attempts to improve adherence and efficacy. Ms. Z may need regular treatment, medication modifications, and psychoeducation to manage her mental health.

References

Cohen, R. J., Schneider, W. J., & Tobin, R. M. (2022).  Psychological testing and assessment: An introduction to tests and measurement (10th ed.). McGraw Hill LLC.